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Objective: To study the expression of CDC20, TOP2A in esophageal 
squamous cell carcinoma and its relationship with survival of esophageal 
carcinoma. Methods: 65 patients with esophageal squamous cell carcino-
ma from January 2016 to June 2018 were selected by computer random 
selection. All patients were treated with radical operation. The CDC20, 
TOP2A expression of the patients was examined. At the same time, the 
relationship between 3-year survival rate and CDC20, TOP2A was ana-
lyzed by follow-up investigation. Results: the CDC20, TOP2A expres-
sion level of cancer tissue group was higher than that of adjacent tissue 
group and normal tissue group (P <0.05), and the CDC20, TOP2A expres-
sion level of adjacent tissue group was higher than that of normal tissue 
group (P <0.05). There was no significant difference in sex, age, tumor 
size, tumor location and CDC20, TOP2A expression level in patients with 
esophageal squamous cell carcinoma, P >0.05; there were differences 
between groups (P P >0.05) and positive proportion in TNM stage, lym-
phatic metastasis, invasion factor and CDC20, TOP2A expression level; 
there were differences in tumor differentiation, 5-year survival rate and 
CDC20, TOP2A expression level (P P >0.05), and showed inverse pro-
portion relationship. Conclusion: metastasis, recurrence and prognosis of 
esophageal squamous cell carcinoma are related to the level of CDC20, 
TOP2A expression. These two indexes can effectively evaluate the patho-
logical situation of esophageal cancer and provide an important reference 
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1. Introduction
As the level of medical science continues to im-prove, the biological mechanism and analysis of esophageal squamous cell carcinoma are 
also more in-depth. TOPA2 expression and tumor cell 
death are related to the mechanism of gene and protein 
formation of esophageal squamous cell carcinoma. It 
is also found that cell division cycle protein 20 plays 
a role in promoting tumor cell infiltration. Based on 
this, this paper will analyze the causes of esophageal 
squamous cell carcinoma from the aspects of tumor 
cell proliferation and tumor cell division, and study the 
expression and survival relationship between CDC20, 
TOP2A and esophageal squamous cell carcinoma tis-
sue, in order to provide new research ideas and meth-
ods for the industry.
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2. Clinical Data and Methods
2.1 Clinical Information
Random selection by computer, From January 2019 to 
June 2020,65 patients with esophageal squamous cell car-
cinoma, All patients underwent radical surgery, Pathologi-
cal specimens during surgery, All patients were diagnosed 
as esophageal squamous cell carcinoma. In radical surgery 
for esophageal cancer, Fresh tissue samples, It was di-
vided into cancer tissue group, adjacent tissue group and 
normal tissue group. Of the 65 patients, 45 males, Twenty 
women, Forty patients aged under 60, 25 patients over 60 
years of age; According to the size of the tumor, 39 cases 
less than 5 cm, 26 cases greater than 5 cm; According to 
the tumor focus, In the last 35 cases, 30 cases in the lower 
section; According to TNM staging criteria, Eight cases in 
the first phase, 29 cases in phase II, There were 16 cases 
in phase III, The fourth stage was 12 cases; Depending on 
the tumor, In 36 cases, Low differentiation into 29 cases; 
Based on lymphatic metastasis, Lymphatic metastasis, 27 
cases, No lymphatic metastasis in 38 cases; According to 
the vein infiltration, In 26 cases, No venous infiltration 
in 39 cases; Based on survival, More than three years, 34 
cases, Less than three years was 31 cases.
2.2 Inspection Methods
The specimens were fixed for 4-6 hours according to the ba-
sic formaldehyde (10% concentration), treated with gradient 
dehydration, waxed tissue, paraffin embedded treatment, 
expanded sections, stained with immunohistochemical S-P 
method, and read films with microscope. The gray value of 
CDC20, TOP2A expression in esophageal squamous cell 
carcinoma was observed by using image processing system. 
The results were determined by two experienced pathologists 
in the case of double-blind method, with the help of high 
power microscope to observe the tumor cells, the nucleus or 
cytoplasm produced yellow or brown granules, which were 
incorporated into the positive cells. Five visual fields were 
randomly selected for each specimen, 100 tumor cells were 
counted in each field, and a total of 500 tumor cells were 
counted. The positive cell rate of more than 10% is positive, 
and the positive cell rate of less than 10% is negative [1]. 
Meanwhile, using semi-quantitative reverse transcription 
polymerase chain reaction, the expression of CDC20, TOP2A 
in pathological tissue was tested, gene RNA was extracted 
according to the standard of Trizol RNA kit, DEPC prepa-
ration was carried out, and then the whole study of agarose 
gel electrophoresis identification mRNA was carried out. 
Through the use of real-time quantitative PCR equipment 
for standard gene amplification processing, with the help of 
ultraviolet gel imaging equipment and analysis equipment 
in the observation function, scanning function, photo-taking 
function, the CDC20, TOP2A and β-actin expression intensi-
ty was calculated and studied.
2.3 Statistical Treatment
This clinical basic data all uses the statistics processing 
way, the statistics software system SPSS 21.0 version, the 
count data is expressed in the percentage, uses the x2 Test, 
when the result is P <0.05, prove that there is statistical 
difference between groups.
3. Results
3.1 CDC20, TOP2A Expression in Esophageal 
Squamous Cell Carcinoma
By means of immunohistochemical S-P, it was found that 
the tumor cells showed a nest-like distribution pattern, 
accompanied by irregular cell series, mainly cell hetero-
morphism and nuclear mitosis.
3.2 Analysis of CDC20, TOP2A Expression in 
Different Esophageal Squamous Cell Carcinoma 
Specimens
The CDC20, TOP2A expression level of cancer tissue 
group was higher than that of adjacent tissue group and 
normal tissue group (P <0.05), and the CDC20, TOP2A 
expression level of adjacent tissue group was significant-
ly higher than that of normal tissue group (P <0.05), as 
shown in Table 1.
Table 1. Analysis of CDC20, TOP2A expression in differ-




























0.756±0.153 7.356±3.174 0.410±0.084 37.081±1.750
Note: Compared with normal tissue groups,*P <0.05; paracancerous tis-
sue compared to normal tissue,＃P <0.05
3.3 Relationship between CDC20, TOP2A Expres-
sion and Esophageal Squamous Cell Carcinoma
There was no significant difference in gender, age, tumor 
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size, tumor location and CDC20, TOP2A expression in 
patients with esophageal squamous cell carcinoma, P 
>0.05. There were differences (P P >0.05) and positive 
proportional relationship between groups in TNM stage, 
lymphatic metastasis and invasion factors and CDC20, 
TOP2A expression level, as shown in Table 2.
Table 2. Analysis of the relationship between CDC20, 
TOP2A expression and clinical characteristics of esopha-







2 P TOP2A positive X
2 P
Gender 0.1909 0.6622 0.0172 0.8957
Male 45 29 30
Female 20 14 13
Age (years) 0.8739 0.3498 2.3029 0.1291
Less than 60 40 26 23
>60 25 19 19
Tumor size 
(cm) 0.0469 0.8285 0.1794 0.6718
Less than 5 39 26 26
greater than 
5 26 18 16
Tumor loca-
tion 1.5043 0.2200 0.0076 0.9305
Upper para-






sis 2.8715 0.0004 1.2544 0.0006
I 8 3 3
II 29 19 17
III 16 13 13
IV 12 11 11
Tumor differ-






tiation 29 28 27
lymphatic 
metastasis 5.4572 0.0194 4.5772 0.0323
Yes 27 25 25
No 38 26 27
Venous infil-
tration 5.7778 0.0162 8.0264 0.0046
Yes 26 24 25
No 39 26 26
Survival 5.0679 0.0243 7.0172 0.0080
Less than 3 
years 31 28 29
More than 3 
years 34 26 26
4. Discussion
The pathogenesis of esophageal squamous cell carcinoma 
is caused by many factors, many processes and many gene 
changes. However, abnormal cell cycle regulation and 
imbalance of cell growth are also the main mechanisms 
of esophageal squamous cell carcinoma tumor formation. 
Based on this, most researchers believe that according to 
the mechanism of esophageal squamous cell carcinoma 
tumor proliferation and invasion analysis, the sensitivity 
and specific diagnostic criteria to meet the treatment of 
esophageal squamous cell carcinoma are analyzed to eval-
uate the metastasis, recurrence and prognosis of esopha-
geal squamous cell carcinoma [2].
CDC20, as a cyclin, is also the core protein to ensure 
the routine implementation of cell mitosis. It regulates 
the S and G2/M stages of cell mitosis, promotes the 
DNA of cell chromosomes to complete mitosis replica-
tion, and is also a whole regulator. It can promote the 
APC/C of late complex / periodic body. Clinical studies 
have shown that CDC20 abnormal expression can cause 
mitosis errors and induce mutations in tumor suppressor 
genes [3]. At present, clinical studies have found that there 
is some correlation between the activation of esophageal 
squamous cell carcinoma and proto-oncogene, the inacti-
vation of tumor suppressor gene, and the dysfunction of 
regulatory proteins that promote DNA repair and main-
tain gene stability [4].
The results showed that the expression level of esopha-
geal squamous cell carcinoma was high, and the CDC20, 
TOP2A expression level was higher, compared with the 
adjacent tissue and normal tissue, and the difference be-
tween CDC20, TOP2A groups was significant. At the 
same time, there was a proportional relationship with 
TNM analysis, tumor differentiation, lymphatic metastasis 
and tumor invasion. Hence, there is a certain correlation 
between CDC20, TOP2A and esophageal squamous cell 
carcinoma. moreover, the results also demonstrated that 
the main factors affecting the prognosis survival of pa-
tients with esophageal squamous cell carcinoma were 
TBN stage iii-phase iv, highly differentiated tumors, lym-
phatic metastasis, and venous infiltration, especially when 
the TNM stage was more severe, the index expression was 
further increased.
However, the metastasis, recurrence and prognosis of 
esophageal squamous cell carcinoma are related to the 
level of CDC20, TOP2A expression. These two index-
es can effectively evaluate the pathological situation of 
esophageal cancer and provide an important reference for 
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